Vicks NyQuilCough (The Procter & Gamble Manufacturing Company)
Welcome to the PulseAid listing for the Vicks NyQuil drug offered from The Procter & Gamble Manufacturing Company. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | The Procter & Gamble Manufacturing Company |
NON-PROPRIETARY NAME: | Dextromethorphan Hydrobromide and Doxylamine succinate |
SUBSTANCE NAME: | DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2011-06-22 |
END MARKETING DATE: | 0000-00-00 |
Vicks NyQuil Cough HUMAN OTC DRUG Details:
Item Description | Vicks NyQuil Cough from The Procter & Gamble Manufacturing Company |
LABELER NAME: | The Procter & Gamble Manufacturing Company |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30; 12.5(mg/30mL; mg/30mL) |
START MARKETING DATE: | 2011-06-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 37000-550_501fc3f5-91be-4a6d-ae77-5b542d869078 |
PRODUCT NDC: | 37000-550 |
APPLICATION NUMBER: | part341 |
Other DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE Pharmaceutical Manufacturers / Labelers: